on:
NCPR is supported by:
 Hourly Newscast4 min., 45 sec.
|
Programs
Latest program rundownComing up:
Latest Features:
May 24, 2013 | NPR ·
May 24, 2013 | NPR ·
May 24, 2013 | NPR ·
Latest program rundownComing up:
Latest Features:
May 24, 2013 | NPR ·
May 24, 2013 | NPR ·
May 24, 2013 | NJN ·
Latest Saturday rundownWE Saturday Feature
May 18, 2013 | NPR ·
Latest Sunday rundown
WE Sunday Feature
May 19, 2013 | NPR ·
prostate cancer
May 3, 2013 — The American Urological Association released new guidelines that, if they're heeded, would dramatically reduce the ranks of men who would be candidates for PSA testing. The prostate-specific antigen test can catch cancer early, but it frequently gives false alarms.
Comments |
Feb 5, 2013 — Testing for prostate cancer may not get any less confusing anytime soon. But researchers say the much-maligned PSA screening test is worthwhile if it's used for the right men at the right time.
Comments |
Oct 29, 2012 — Proton therapy can be targeted much more precisely than regular radiation. The hope is that it translates into far fewer side effects, such as impotence and incontinence. But it also costs twice as much as regular radiation. And there's no proof it's more effective — it could potentially be worse, say some radiation experts.
Sep 6, 2012 — There are conflicting guidelines on when women should get mammograms and mounting questions on when the PSA blood test for prostate cancer is worthwhile. We asked how people are sorting things out.
Comments |
Jul 18, 2012 — A study of more than 700 men with prostate cancer found no difference in rates of death among men who had their prostates surgically removed compared to those who didn't. The findings suggest that men with low-risk cancers could forgo surgery.
Comments |
May 28, 2012 — A federal task force's recommendations against routine blood tests for prostate cancer raises big questions about how to interpret medical evidence and what role expert panels should play in how doctors practice. But those questions aren't easy to answer.
May 24, 2012 — Johns Hopkins researcher round that nearly three-quarters of primary care doctors they surveyed said their patients expected regular PSA screening to continue. The findings suggest there will be
Comments |
May 23, 2012 — The U.S. Preventive Services Task Force said the harms, such as false alarms and unnecessary surgeries that leave some men impotent and incontinent, outweigh the benefits of routine PSA blood testing for prostate cancer. But it's far from clear that doctors and their patients will heed the advice.
Comments |
May 21, 2012 — The U.S. Preventive Services Task Force says the testing doesn't save enough lives to justify the risk of unnecessary surgery and radiation. But one testing supporter says, "If all PSA screening were to stop, there would be thousands of men who would unnecessarily suffer and die from prostate cancer."
Apr 18, 2012 — Billionaire Warren Buffett was tested for prostate cancer at an age when most men are not. The evidence suggests that in most cases the harms of treatment of prostate cancer in elderly men outweigh its benefits.
Comments |
